20% of Antibodies not specific?

  • Thread starter Thread starter gravenewworld
  • Start date Start date
  • Tags Tags
    Antibodies Specific
AI Thread Summary
The discussion centers on the validation of reagents, particularly antibodies, in academic versus industrial settings. It highlights a perceived discrepancy where academia often neglects proper validation, leading to potential misinterpretations of results due to nonspecific binding. Critics argue that the peer review process fails to address these issues, allowing flawed studies to proliferate. Some participants emphasize the importance of validating antibodies, noting that many commercial products lack specificity. There is a call for academia to adopt industry standards for validation, while others counter that not all antibodies are equally effective across different applications. The conversation also touches on the necessity of negative controls and the optimization of protocols for varying experimental conditions. Additionally, there is a critique of the original paper's relevance to the topic of reagent validation, suggesting a misunderstanding of its content.
gravenewworld
Messages
1,128
Reaction score
27
Nice little paper about properly validating your reagents:

http://www.ncbi.nlm.nih.gov/pubmed/22361696Why is it in academia absolutely no one validates their reagents like antibodies while in industry it is absolutely required?

Rather than admitting their results are due to nonspecific binding, I've seen some papers where academics attribute their results to say something like another unknown isoform of the protein that they're studying.

Why is it that the peer review system has completely and utterly failed to to address this type of terrible science? What's worse is that once results that come from an antibody that might not be specific is published, many other labs go out and start using the same antibody to study the protein(s) in question.

What a complete an utter joke a lot of science being done now has become. Manufacturers are notorious for being lazy when it comes to validating their antibodies, academics simply take it for granted that they are supposed to work. Maybe it is time our universities do high quality science with validation like industry?
 
Biology news on Phys.org
I always validate my antibodies and indeed I've found many commercial antibodies to be non-specific. I don't recognize your statement that in academia no one validates their reagents. What I wonder is whether the paper you cite has validated the specificity of the siRNA :biggrin:
 
gravenewworld said:
Nice little paper about properly validating your reagents:

http://www.ncbi.nlm.nih.gov/pubmed/22361696

<snip>

I won't have access to the full article until Tuesday (access thru work), but based on the abstract, I don't understand why you say the article concerns validation of reagents. I read the abstract as validation of a method to measure the spatial distribution of expressed proteins by siRNA (alternatively, validation of the siRNA method as per Monique).

Why do you say "validates their reagents like antibodies"?
 
I don't find the paper impressive and they appear to ignore the fact that knockdown might not be efficient or has off-target effects. The idea to use siRNA to verify protein localization is not new.

gravenewworld said:
Why is it in academia absolutely no one validates their reagents like antibodies while in industry it is absolutely required?

The statement that absolutely no one validates their reagents is ridiculous, it makes me wonder what field you are into have such a view. The statement that in industry the validation is absolutely required is not valid either since I mentioned that commercial antibodies can also be a-specific. I would applaud it if these antibody selling companies would validate their products.
 
To play Devil's advocate, there are other uses for antibodies than immunofluoresence and often the antibodies that work well for immunofluorescence do not work well for these other applications (such as Western blotting). So, these 20% of commercially available antibodies that don't seem to work well aren't necessarily worthless (although from experience, I've come across plenty of commercially available antibodies that don't seem to work well for any purpose).
 
Ygggdrasil said:
To play Devil's advocate, there are other uses for antibodies than immunofluoresence and often the antibodies that work well for immunofluorescence do not work well for these other applications (such as Western blotting). So, these 20% of commercially available antibodies that don't seem to work well aren't necessarily worthless (although from experience, I've come across plenty of commercially available antibodies that don't seem to work well for any purpose).

Sure- most manufacturers even suggest 'optimal' applications (for primary antibodies: ELISA, WB, IP, IF, etc.), see http://igene.invitrogen.com/isearch/antibody.do

It's also true that *negative* controls should *always* be performed to check against non-specific binding (for example). Lastly, since experimental systems vary so widely all protocols: immunohistochemistry, siRNA, transfection, etc, must be carefully optimized: what works on one cell type may not work on another.

The OP did not understand the content of the linked article.
 
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...
I use ethanol for cleaning glassware and resin 3D prints. The glassware is sometimes used for food. If possible, I'd prefer to only keep one grade of ethanol on hand. I've made sugar mash, but that is hardly the least expensive feedstock for ethanol. I had given some thought to using wheat flour, and for this I would need a source for amylase enzyme (relevant data, but not the core question). I am now considering animal feed that I have access to for 20 cents per pound. This is a...

Similar threads

Replies
2
Views
2K
Replies
93
Views
17K
Replies
15
Views
2K
Replies
27
Views
2K
Replies
2
Views
2K
Replies
3
Views
2K
Replies
8
Views
3K
Back
Top